![Jonathan Haug](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mr. Jonathan R.
Haug is a President & Director at Atai Beckley, Inc., a President & Director at Ventyx Biosciences, Inc., a President & Director at Adverum Biotechnologies, Inc., a President at Verve Therapeutics, Inc., a Chief Executive Officer at ARMO Biosciences, Inc., a Chief Executive Officer at DICE Therapeutics, Inc., a President & Director at Morphic Holding, Inc. and a President & Director at Scorpion Therapeutics, Inc. He is on the Board of Directors at Atai Beckley, Inc., Ventyx Biosciences, Inc., Adverum Biotechnologies, Inc., Morphic Holding, Inc. and Scorpion Therapeutics, Inc. Mr. Haug was previously employed as a Chief Executive Officer by Prevail Therapeutics, Inc.
Postes actifs de Jonathan Haug
| Sociétés | Poste | Début |
|---|---|---|
| VERE THER | President | 25/07/2025 |
| ADVERUM BIOTECHNOLOGIES, INC. | President | 09/12/2025 |
| VENTYX BIOSCIENCES, INC. | President | 04/03/2026 |
| MORC HOLD | President | - |
| ARMO BIOSCIENCES INC | Directeur Général | - |
| DICE THER | Directeur Général | - |
Scorpion Therapeutics, Inc.
 Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision oncology therapies for cancer treatment | President | - |
Anciens postes connus de Jonathan Haug
| Sociétés | Poste | Fin |
|---|---|---|
| PREVAIL THERAPEUTICS INC. | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
58
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops gene therapies | Health Technology |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer | Health Technology |
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology Develops oral immunology and other therapeutic products | Health Technology |
Morphic Holding, Inc.
 Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for neurodegenerative diseases | Health Technology |
Verve Therapeutics, Inc.
 Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
Scorpion Therapeutics, Inc.
Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision oncology therapies for cancer treatment | Health Technology |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
